Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The protein p21 (WAF1, CIP1 or sdi1), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression. One of these is the cyclin-Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin-Cdk kinases and a carboxy-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [49]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Research works printed but not linked: 1
- el-Deiry, W. et al. Cancer Res. 54, 1169–1174 (1994).
Cited by
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
“…and p57Kip2 (Lee et al. 1995; Matsuoka et al. 1995), all of which contain characteristic motifs within their amino-terminal moieties that enable them to bind both to cyclin and CDK subunits (Chen et al. 1995, 1996; Nakanishi et al. 1995; Warbrick et al. 1995; Lin et al. 1996; Russo et al. 1996).”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
“p21-mediatedgrowth inhibition has been attributed to two main activities that depend on two non-overlapping structural domains: the carboxy-terminal PCNA-binding domain and the amino-terminal CDK–cyclin inhibitory domai”
BackgroundSelf-citationNew functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142
“The Cip/Kip proteins interact with a variety of cyclin–CDK complexes through a conserved N-terminal domain that contains both cyclin and CDK binding sites (Toyoshima and Hunter, 1994; Chen et al., 1995, 1996; Luo et al., 1995; Nakanishi et al., 1995; Lin et al., 1996; Russo et al., 1996).”
BackgroundZhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
“The nuclear localization of p21 Cip1/WAF1 seems to be responsible for its inhibition of cell growth and is controlled by the NLS at its carboxy terminu”
BackgroundProliferating cell nuclear antigen (PCNA): a dancer with many partners
Maga, G., & Hübscher, U. (2003) · Journal of Cell Science · doi:10.1242/jcs.00653 · Cited by 1,096
“…-independent pathways induces the expression of the p21 protein, which blocks progression from G1 to S phase of the cell cycle. p21 binds to CDKs through its N-terminal region and to PCNA through its C-terminal region (Chen et al., 1995; Luo et al., 1995; Chen et al., 1996; Moskowitz et al., 1996).”
BackgroundCensus and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.
Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 1,075
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907
Wilcox, D. E. (1996) · Chemical Reviews · doi:10.1021/cr950043b · Cited by 893
THE DNA REPLICATION FORK IN EUKARYOTIC CELLS
Waga, S., & Stillman, B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.721 · Cited by 820
Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA
Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M., & Kuriyan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81347-1 · Cited by 804
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Functional Analysis of Cyclin-Dependent Kinase Inhibitors of Arabidopsis
De Veylder, L., Beeckman, T., Beemster, G. T. S., Krols, L., Terras, F., Landrieu, I., Van Der Schueren, E., Maes, S., Naudts, M., & Inzé, D. (2001) · The Plant Cell · doi:10.1105/tpc.010087 · Cited by 640
“Kip/Cip family members are reported to interact with many other regulatory proteins, including the proliferating cell nuclear antigen (Chen et al., 1995), the coactivator of c-Jun JAB1 (Tomoda et al., 1999), and the syntaxin-like molecule CARB (McShea et al., 2000).”
BackgroundApoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586
“The gene product also binds proliferating cell nuclear antigen (PCNA) through its C-terminal domain and blocks the ability of PCNA to activate DNA polymerase δ, the principal replicative DNA polymerase (Waga et al., 1994; Chen et al., 1995; Luo et al., 1995; Sherr and Roberts, 1995).”
BackgroundHeger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., & Wright, P. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11504 · Cited by 575
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Poly(ADP-ribose) Binds to Specific Domains in DNA Damage Checkpoint Proteins
Pleschke, J. M., Kleczkowska, H. E., Strohm, M., & Althaus, F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006520200 · Cited by 541
High speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., & Galloway, D. A. (1997) · Genes & Development · doi:10.1101/gad.11.16.2090 · Cited by 419
Chemistry of Glycosylases and Endonucleases Involved in Base-Excision Repair
David, S. S., & Williams, S. D. (1998) · Chemical Reviews · doi:10.1021/cr980321h · Cited by 512
Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation
Wang, J., & Walsh, K. (1996) · Science · doi:10.1126/science.273.5273.359 · Cited by 489
p53 in growth control and neoplasia
Gottlieb, T. M., & Oren, M. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00019-c · Cited by 481
p21WAF1/Cip1: more than a break to the cell cycle?
Dotto, G. P. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00019-6 · Cited by 474
Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., & Ross, R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80055-6 · Cited by 441
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.009 · Cited by 433
“The idea that p21 could play a role in DNA repair was first suggested by the evidence showing that p21 interacts with PCNA [9,10,13–16].”
BackgroundCyclin-dependent kinase control of centrosome duplication
Lacey, K. R., Jackson, P. K., & Stearns, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2817 · Cited by 427
Self-citationVisone, R., Russo, L., Pallante, P., De Martino, I., Ferraro, A., Leone, V., Borbone, E., Petrocca, F., Alder, H., Croce, C. M., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0129 · Cited by 417
“…human miR gene targets, we identified the CDKN1B (p27Kip1) gene as a putative target of miR-221 and miR-222. p27Kip1, amember of theCip/Kip familywhich also includes p21Cip1 and p57Kip2, represents a very important regulator of cell cycle (Gu et al. 1993, Polyak et al. 1994, Chen et al. 1995).”
BackgroundMetal Activation of Enzymes in Nucleic Acid Biochemistry
Cowan, J. A. (1998) · Chemical Reviews · doi:10.1021/cr960436q · Cited by 406
A p53-Dependent Checkpoint Pathway Prevents Rereplication
Vaziri, C., Saxena, S., Jeon, Y., Lee, C., Murata, K., Machida, Y., Wagle, N., Hwang, D. S., & Dutta, A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00099-6 · Cited by 393
“22, 123–131.described (Chen et al., 1995, 1996).”
Self-citationINITIATION OF DNA REPLICATION IN EUKARYOTIC CELLS
Dutta, A., & Bell, S. P. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.293 · Cited by 393
Self-citationSambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H., & Cohen, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34940 · Cited by 390
Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., & Arnold, A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0373 · Cited by 375
Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence
Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z., Lee, S. W., & Aaronson, S. A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2180 · Cited by 374
Adams, P. D., Sellers, W. R., Sharma, S. K., Wu, A. D., Nalin, C. M., & Kaelin, W. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6623 · Cited by 373
“There are two such motifs within p21, one at the N terminus and one, unexpectedly in light of previously published data, at the C terminus (7, 18, 21, 43, 47, 54, 78).”
BackgroundInfluentialRössig, L., Jadidi, A. S., Urbich, C., Badorff, C., Zeiher, A. M., & Dimmeler, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5644-5657.2001 · Cited by 370
Dacapo, a Cyclin-Dependent Kinase Inhibitor, Stops Cell Proliferation during Drosophila Development
Lane, M. E., Sauer, K., Wallace, K., Jan, Y. N., Lehner, C. F., & Vaessin, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81818-8 · Cited by 327
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
“Plasmids used for expression of various proteins in bacteria were pETp21His (44), pETp27His (36), pETCdk2 (3), pGST-RbC (20), pGST-cyclin D1,2,3 (from Yue Xiong), and pGST-cyclin E (17).”
BackgroundMethodInfluentialSelf-citationMissero, C., Di Cunto, F., Kiyokawa, H., Koff, A., & Dotto, G. P. (1996) · Genes & Development · doi:10.1101/gad.10.23.3065 · Cited by 312
Pro‐apoptotic effect of endogenous H 2 S on human aorta smooth muscle cells
Yang, G., Wu, L., & Wang, R. (2006) · The FASEB Journal · doi:10.1096/fj.05-4712fje · Cited by 303
“p21 is one of the cdk inhibitory proteins, and it can prevent cell cycle progress by directly binding with phosphorylated cyclin D1 and cdk complexes (24, 25).”
BackgroundInitiation of DNA Replication Requires the RECQL4 Protein Mutated in Rothmund-Thomson Syndrome
Sangrithi, M. N., Bernal, J. A., Madine, M., Philpott, A., Lee, J., Dunphy, W. G., & Venkitaraman, A. R. (2005) · Cell · doi:10.1016/j.cell.2005.05.015 · Cited by 291
Cyclin dependent kinase regulation
Lees, E. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80060-3 · Cited by 285
Blain, S. W., Montalvo, E., & Massagué, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25863 · Cited by 279
Circadian molecular clocks and cancer
Kelleher, F. C., Rao, A., & Maguire, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.09.040 · Cited by 276
“p21 possesses a number of effector functions, including growth inhibition [79], regulation of gene transcription [80], modulating apoptosis [81] and DNA repair [82].”
BackgroundCell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.
Kim, H.-R. C., Lin, H. M., Biliran, H., & Raz, A. (1999) · PubMed · Cited by 316
Sutherland, R. L., & Musgrove, E. A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023591.45568.77 · Cited by 258
Human Cyclin a Is Required for Mitosis until Mid Prophase
Furuno, N., den Elzen, N., & Pines, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.295 · Cited by 261
“The carboxyl terminus of p21 Cip1/Waf1/Sic1 is also able to bind to PCNA (Chen et al., 1995; Goubin and Ducommun, 1995; Nakanishi et al., 1995; Warbrick et al., 1995), and this appears to contribute to a DNA damage checkpoint when p21 Cip1/Waf1/Sic1 is overexpressed (Tournier et al., 1996; Cayrol et al., 1998).”
BackgroundInfluentialSaha, P., Chen, J., Thome, K. C., Lawlis, S. J., Hou, Z.-H., Hendricks, M., Parvin, J. D., & Dutta, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2758 · Cited by 256
Self-citationp107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
Zhu, L., Harlow, E., & Dynlacht, B. D. (1995) · Genes & Development · doi:10.1101/gad.9.14.1740 · Cited by 252
PCNA Is a Cofactor for Cdt1 Degradation by CUL4/DDB1-mediated N-terminal Ubiquitination
Senga, T., Sivaprasad, U., Zhu, W., Park, J. H., Arias, E. E., Walter, J. C., & Dutta, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512705200 · Cited by 250
Self-citationThe Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis
Herwig, S., & Strauss, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00581.x · Cited by 250
Gary, R., Ludwig, D. L., Cornelius, H. L., MacInnes, M. A., & Park, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24522 · Cited by 238
Polymorphisms in the p53 pathway
Pietsch, E. C., Humbey, O., & Murphy, M. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209367 · Cited by 237
“In addition to exerting regulatory influences on the cell cycle, p21/Waf1 affects DNA replication by interaction with the proliferating cell nuclear antigen (PCNA) (Flores-Rozas et al., 1994; Waga et al., 1994).”
BackgroundInfluentialZhang, Y., Fujita, N., & Tsuruo, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202426 · Cited by 237
“As the N-terminus of p21 was responsible for the binding to the CDK2 (Chen et al., 1995; Nakanishi et al., 1995a), both p21DC and p21WT could bind to the CDK2 (Figure 4a).”
BackgroundResultInfluentialWu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T. (1996) · Genes & Development · doi:10.1101/gad.10.3.245 · Cited by 234
Regulation of CDK/cyclin complexes during the cell cycle
Arellano, M., & Moreno, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00178-1 · Cited by 236
A non-enzymatic p21 protein inhibitor of stress-activated protein kinases
Shim, J., Lee, H., Park, J., Kim, H., & Choi, E.-J. (1996) · Nature · doi:10.1038/381804a0 · Cited by 236
G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells
Blajeski, A. L., Phan, V. A., Kottke, T. J., & Kaufmann, S. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13275 · Cited by 200
Mimura, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5699 · Cited by 233
“With Xenopus egg extracts, it has been established that p21(Cip1), inhibits replication through the inhibition of S-phase-cdk activity in the extract (Strausfeld et al., 1994; Chen et al., 1995; Jackson et al., 1995).”
BackgroundMechanism of CRL4Cdt2, a PCNA-dependent E3 ubiquitin ligase
Havens, C. G., & Walter, J. C. (2011) · Genes & Development · doi:10.1101/gad.2068611 · Cited by 224
“It is clear in vitro that p21 can inhibit DNA replication and repair through direct binding to PCNA via the PIP box in p21 (Chen et al. 1995; Cooper et al. 1999; Bendjennat et al. 2003).”
BackgroundCdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1
Martín, A., Odajima, J., Hunt, S. L., Dubus, P., Ortega, S., Malumbres, M., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.006 · Cited by 223
“For instance, p21Cip1 uses this domain to bind to the proliferating-cell nuclear antigen (PCNA), a DNA polymerase delta processivity factor, thus preventing DNA replication (Chen et al., 1995; Waga et al., 1994; Li et al., 1994; Luo et al., 1995).”
Backgroundp27Xic1, a Cdk Inhibitor, Promotes the Determination of Glial Cells in Xenopus Retina
Ohnuma, S.-I., Philpott, A., Wang, K., Holt, C. E., & Harris, W. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81538-x · Cited by 219
“There PCNA-binding region that is also found in p21Cip1 (Wagawas no difference in apoptosis between p27Xic1-transet al., 1994; Chen et al., 1995) and a potential cdc2fected cells and the cells transfected with GFP alone at phosphorylation site, the QT domain that is also foundany stage examined,…”
Mcm10 and And-1/CTF4 recruit DNA polymerase α to chromatin for initiation of DNA replication
Zhu, W., Ukomadu, C., Jha, S., Senga, T., Dhar, S. K., Wohlschlegel, J. A., Nutt, L. K., Kornbluth, S., & Dutta, A. (2007) · Genes & Development · doi:10.1101/gad.1585607 · Cited by 214
“Consistent with this, inhibition of cdk2 kinase by addition of the cdk inhibitor GST-p21N (Chen et al. 1995) to the egg extracts blocked the loading of And-1 and Cdc45 to chromatin (Fig.”
BackgroundMethodSelf-citationTsurimoto, T. (1999) · Frontiers in Bioscience · doi:10.2741/a469 · Cited by 213
Gervais, J. L. M., Seth, P., & Zhang, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19207 · Cited by 212
Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism
Shih, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1223 · Cited by 208
Fang, L., Igarashi, M., Leung, J., Sugrue, M. M., Lee, S. W., & Aaronson, S. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202615 · Cited by 207
“…1994; Harper et al., 1995; Medema et al., 1995). p21Waf1/Cip1/Sdi1 can also bind to proliferating cell nuclear antigen (PCNA), a subunit of DNA polymerase d which is involved in DNA replication and repair (Flores-Rozas et al., 1994; Waga et al., 1994; Chen et al., 1995; Nakanishi et al., 1995).”
BackgroundTelomerase in human development and cancer
Shay, J. W. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<266::aid-jcp33>3.0.co;2-b · Cited by 141
Bruning, J. B., & Shamoo, Y. (2004) · Structure · doi:10.1016/j.str.2004.09.018 · Cited by 206
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
Jin, Y., Lee, H., Zeng, S. X., Dai, M., & Lu, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg600 · Cited by 206
Ando, T., Kawabe, T., Ohara, H., Ducommun, B., Itoh, M., & Okamoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106460200 · Cited by 202
Tying It All Together: Epigenetics, Genetics, Cell Cycle, and Cancer
Baylin, S. B. (1997) · Science · doi:10.1126/science.277.5334.1948 · Cited by 202
Early events in DNA replication require cyclin E and are blocked by p21CIP1.
Jackson, P. K., Chevalier, S., Philippe, M., & Kirschner, M. W. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.755 · Cited by 200
“Recent studies have also seen that p21 can block sperm replication (Strausfeld et al., 1994; Adachi and Laemmli, 1994; Yan and Newport, 1995) and that this inhibition is mediated by the NH2-terminal cyclin/Cdk2 binding domain of p21, which binds to cyclin/Cdk2 (Chen et al., 1995).”
BackgroundInfluentialSelf-citationLee, J., Kumagai, A., & Dunphy, W. G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00045-5 · Cited by 198
CLINICAL IMPLICATIONS OF THE p53 GENE
Sidransky, M. D., & Hollstein, P. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.285 · Cited by 194
WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases
Ogryzko, V. V., Wong, P., & Howard, B. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4877 · Cited by 193
“The reason for this may be a relative abundance of PCNA compared to components of the CDK machinery, as has been suggested for the Xenopus egg system (3); accordingly, relatively high levels of WAF1 expression might be necessary FIG.”
BackgroundInfluentialMatsumura, I., Ishikawa, J., Nakajima, K., Oritani, K., Tomiyama, Y., Miyagawa, J.-I., Kato, T., Miyazaki, H., Matsuzawa, Y., & Kanakura, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2933 · Cited by 190
“by on December 11, 2009 mcb.asm.org Downloaded from cellcyclearrestandinhibitionofDNAreplication,respectively ( 5 ,34,60).Expressionofp21WAF1/Cip1isknowntoberegulated by the tumor suppressor protein p53; in response to DNAdamaging agents such as irradiation or anticancer agents, the expression level of p53 increases,…”
BackgroundInfluentialKoga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24024 · Cited by 175
p21/p53, Cellular Growth Control and Genomic Integrity
El-Deiry, W. S. (1998) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-71941-7_6 · Cited by 173
Poon, R. Y. C., Jiang, W., Toyoshima, H., & Hunter, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13283 · Cited by 172
The ABBA Motif Binds APC/C Activators and Is Shared by APC/C Substrates and Regulators
Di Fiore, B., Davey, N. E., Hagting, A., Izawa, D., Mansfeld, J., Gibson, T. J., & Pines, J. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.003 · Cited by 171
“…utilize SLiMs: the canonical RxL Cyclin recognition motif binds the hydrophobic patch of Cyclin A, thereby recruiting numerous substrates (Chen et al., 1995; Zhu et al., 1995); and the Destruction box (D-box) and KEN box degrons (Glotzer et al., 1991; Pfleger and Kirschner, 2000) are…”
BackgroundStewart, Z. A., Leach, S. D., & Pietenpol, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.205 · Cited by 168
“In the cell, cyclin-Cdk-PCNA-p21 complexes are found throughout the cell cycle (29, 61–63); p21 interacts with Cdks via its N terminus and with PCNA via its C terminus (3, 30).”
BackgroundUpdates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
Sobhani, N., D’Angelo, A., Pittacolo, M., Roviello, G., Miccoli, A., Corona, S. P., Bernocchi, O., Generali, D., & Otto, T. (2019) · Cells · doi:10.3390/cells8040321 · Cited by 167
Repression of p27 kip1 Synthesis by Platelet-Derived Growth Factor in BALB/c 3T3 Cells
Agrawal, D., Hauser, P., McPherson, F., Dong, F., Garcia, A., & Pledger, W. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4327 · Cited by 168
“The carboxy-terminal region of p21 allows it to associate with proliferating cell nuclear antigen a processivity subunit of the DNA polymerase d holoenzyme (5, 19, 37, 49, 71).”
BackgroundLongworth, M. S., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3533-3541.2004 · Cited by 163
“Rb family members have also been implicated in controlling cell cycle exit upon epithelial differentiation, and E7 has been shown to block this process (4, 10).”
BackgroundBarnouin, K., Dubuisson, M. L., Child, E. S., Fernandez de Mattos, S., Glassford, J., Medema, R. H., Mann, D. J., & Lam, E. W.-F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111123200 · Cited by 161
Buck, M., Poli, V., Hunter, T., & Chojkier, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00374-4 · Cited by 162
Ishida, A., Sasaguri, T., Kosaka, C., Nojima, H., & Ogata, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10050 · Cited by 161
Yang, G., Cao, K., Wu, L., & Wang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408997200 · Cited by 159
Skp2 in the ubiquitin‐proteasome system: A comprehensive review
Asmamaw, M. D., Liu, Y., Zheng, Y., Shi, X., & Liu, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21675 · Cited by 175
Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
Pei, X.-H., & Xiong, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208611 · Cited by 158
“Subsequent deletion and binding assays demonstrated that p21 contains two functionally independent domains, an N-terminal cyclin–CDK binding domain and a C-terminal PCNA binding domain, thereby bridging the interaction between PCNA and CDK–cyclin (Chen et al., 1995, 1996; Luo et al., 1995; Nakanish et al., 1995a, b; W…”
BackgroundInfluentialCytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity
Tanaka, H., Yamashita, T., Asada, M., Mizutani, S., Yoshikawa, H., & Tohyama, M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202071 · Cited by 157
“inhibits cyclin-Cdk kinases and a COOH-terminal domain of p21 Cip1/WAF1 inhibits proliferating cell nuclear antigen (Waga et al., 1994; Chen et al., 1995; Luo et al., 1995; Sherr and Roberts, 1995).”
BackgroundYan, G.-Z., & Ziff, E. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06122.1997 · Cited by 157
“The p21 protein also inhibits the PCNA protein, an essential DNA replication protein (R. Li et al., 1994; Waga et al., 1994; Chen et al., 1995a; Luo et al., 1995).”
BackgroundWatanabe, H. A., Pan, Z., Schreiber‐Agus, N., DePinho, R. A., Hurwitz, J., & Xiong, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1392 · Cited by 175
Inhibitors of the Cip/Kip Family
Hengst, L., & Reed, S. I. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_2 · Cited by 188
Suzuki, A., Tsutomi, Y., Miura, M., & Akahane, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202409 · Cited by 161
“The Cdk-binding domain in p21 was identi®ed as the 49 ± 71 amino acid region (Nakanishi et al., 1995) and the PCNA-binding domain is found in the 76 ± 164 amino acid region (Chen et al., 1995; Luo et al., 1995).”
BackgroundCell Cycle Regulation and Differentiation in the Human Podocyte Lineage
Nagata, M., Nakayama, K. I., Terada, Y., Hoshi, S., & Watanabe, T. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65739-2 · Cited by 160
Metadata
- Authors
- Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Venue
- Nature
- Published
- 1995-03
- Volume
- 374
- Issue
- 6520
- Pages
- 386-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2078690152
- Cited by
- 548
- References
- 16
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 20
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, WAF1/CIP1, p53, PCNA, proliferating cell nuclear antigen, protein domains, N-terminal domain, C-terminal domain, DNA replication inhibition, cell cycle arrest, growth inhibition, tumour suppressor
- MeSH terms
- Animals, Haplorhini, Binding Sites, Cell Division, Cell Line, Transformed, DNA Replication, Escherichia coli, Humans, Peptide Fragments, Recombinant Fusion Proteins, Simian virus 40, Tumor Cells, Cultured, Xenopus, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Xenopus Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.